SHANGHAI PHARM.HLDG H YC1 earnings per share and revenue

S1R earnings per share for the last quarter are 0.05 EUR whereas the estimation was 0.05 EUR which accounts for 0.00% surprise. Company revenue for the same period amounts to 9.00 B EUR despite the estimated figure of 9.00 B EUR. Estimated earnings per share for the next quarter are 0.05 EUR, and revenue is expected to reach 9.46 B EUR. Also watch annual changes over time to get a bigger picture of S1R earnings per share and revenue dynamics.